• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AVR
Click for more information
1.61% $15.25

ANTERIS TECHNOLOGIES LTD - News & Media

Market Cap $322.3M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Anteris Technologies Ltd is an Australia-based structural heart company. The Company is... Anteris Technologies Ltd is an Australia-based structural heart company. The Company is engaged in designing, developing, and commercializing medical devices. The Company’s lead product, DurAVR, is a transcatheter heart valve (THV) for treating aortic stenosis. DurAVR THV is made using ADAPT tissue, its patented anti-calcification tissue technology. DurAVR THV is a novel first-in-class biomimetic valve made from a single piece of native-shaped tissue. It is designed to mimic the performance of a pre-disease human aortic valve. Its balloon expandable ComASUR Delivery System provides controlled deployment and accurate placement of the DurAVR THV valve, designed to achieve precise alignment with the heart’s native commissures to achieve ideal valve positioning.More

Articles & Videos

Anteris the latest to flee a struggling ASX for Wall Street's NASDAQ

Anteris (ASX:AVR) has announced it intends to re-domicile and set up digs on the Wall Street NASDAQ index – joining Tamboran Energy, and until plans fell through, Telix.

13 Aug 2024 10:24 (AEST)

Anteris Technologies (ASX:AVR) secures utility patent for transcatheter heart valve

Anteris (ASX:AVR) has been issued a utility patent from the US Patent and Trademark Office for its novel DurAVR transcatheter heart valve.

12 Apr 2023 11:21 (AEST)

Anteris Technologies (ASX:AVR) launches $35m capital raise as FDA approves DurAVR study

Anteris Technologies (ASX:AVR) has launched a $35 million capital raise for the clinical development of its DurAVR transcatheter heart valve (THV) system.

09 Feb 2023 14:58 (AEDT)



(20min delay)
Last
$15.25 		Change
-0.250(1.61%) 		Mkt cap ! $322.3M
Open High Low Value Volume
$15.50 $15.50 $14.80 $140.4K 9.315K

Buyers (Bids)

No. Vol. Price($)
1 297 $15.00
 

Sellers (Offers)

Price($) Vol. No.
$15.25 1300 2
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
AVR (ASX) Chart

Top Stories

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

Strategic Energy Resources is 4 holes into a 40-hole RC drill campaign at its Achilles 1 copper-gold target in the Cobar Basin of NSW.
Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions Given the recent fall in iron ore prices below the $100 mark, now might be the time to buy into specialised stocks in the materials sector.
IPH raises $100M to buy up Canadian IP firm Bereskin & Parr IPH Ltd has raised $100 million in an institutional placement to support the acquisition, while also launching a share purchase plan.
Reporting wrap: Inghams, Accent, Mayne Pharma Inghams Group Ltd, Accent Group Ltd and Mayne Pharma Group Ltd all reported final year results for the 2024 fiscal year.
Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt Noronex Limited (ASX:NRX) has kicked off a gravity EM survey at the Damara project in Namibia – part of its earn-in deal with South32.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.